RetinalGenix Technologies

RetinalGenix Technologies Dividend Yield

Dividend Yield of RetinalGenix Technologies (RTGN) as of Nov 5, 2026.

Dividend Yield

-

Last updated:

Dividend Yield of RetinalGenix Technologies is 2026 - . Dividend Yield of RetinalGenix Technologies was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RetinalGenix Technologies Stock analysis

What does RetinalGenix Technologies do? RetinalGenix Technologies Inc, based in Petaluma, California, is a medical device company focused on ocular health. The company develops innovative solutions for screening, monitoring, diagnosing, and treating sight-threatening disorders, particularly diabetic retinopathy and maculopathy. Its key products include the Retinal Imaging Screening Device, a portable system offering a 200-degree field of view without pupil dilation, and RetinalCam, a home monitoring device with 24/7 physician access for real-time communication. Both devices aim to address vision loss and blindness through advanced imaging technology. RetinalGenix Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RetinalGenix Technologies stock

On Eulerpool you can find the complete historical development of Dividend Yield RetinalGenix Technologies since 2006 – with annual values, charts, and detailed analysis.

Dividend yield measures the annual dividend payment relative to the stock price. It shows the return an investor receives from dividends alone.

Dividend Yield's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Yield's RetinalGenix Technologies historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — RetinalGenix Technologies

All Key Metrics — RetinalGenix Technologies